Published on
June 26, 2020
- 05:17 GMT
ZUCERO THERAPEUTICS ANNOUNCES PROMISING COVID-19 VIRUS LABORATORY RESULTS
• Zucero’s clinical-stage drug candidate pixatimod demonstrates potent antiviral activity against the COVID-19 virus in laboratory studies. BRISBANE, QUEENSLAND, AUSTRALIA, June 26, 2020 /EINPresswire.com/ -- ZUCERO THERAPEUTICS ANNOUNCES PROMISING …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Science
...